TY - JOUR
T1 - Phenotype of Peripheral NK Cells in Latent, Active, and Meningeal Tuberculosis
AU - Choreño-Parra, José Alberto
AU - Jiménez-Álvarez, Luis Armando
AU - Maldonado-Díaz, Ellis Daniela
AU - Cárdenas, Graciela
AU - Fernández-Lopez, Luis Alejandro
AU - Soto-Hernandez, José Luis
AU - Muñoz-Torrico, Marcela
AU - Ramírez-Martínez, Gustavo
AU - Cruz-Lagunas, Alfredo
AU - Vega-López, Armando
AU - Domínguez-López, María Lilia
AU - Sánchez-Garibay, Carlos
AU - Guadarrama-Ortíz, Parménides
AU - Giono, Silvia
AU - Jiménez-Zamudio, Luis Antonio
AU - Khader, Shabaana A.
AU - García-Latorre, Ethel A.
AU - Salinas-Lara, Citlaltepetl
AU - Zúñiga, Joaquín
N1 - Publisher Copyright:
© 2021 José Alberto Choreño-Parra et al.
PY - 2021
Y1 - 2021
N2 - The mechanisms underlying the immunopathology of tuberculous meningitis (TBM), the most severe clinical form of extrapulmonary tuberculosis (TB), are not understood. It is currently believed that the spread of Mycobacterium tuberculosis (Mtb) from the lung is an early event that occurs before the establishment of adaptive immunity. Hence, several innate immune mechanisms may participate in the containment of Mtb infection and prevent extrapulmonary disease manifestations. Natural killer (NK) cells participate in defensive processes that distinguish latent TB infection (LTBI) from active pulmonary TB (PTB). However, their role in TBM is unknown. Here, we performed a cross-sectional analysis of circulating NK cellCID="C008"value="s"phenotype in a prospective cohort of TBM patients (n=10) using flow cytometry. Also, we addressed the responses of memory-like NK cell subpopulations to the contact with Mtb antigens in vitro. Finally, we determined plasma levels of soluble NKG2D receptor ligands in our cohort of TBM patients by enzyme-linked immunosorbent assay (ELISA). Our comparative groups consisted of individuals with LTBI (n=11) and PTB (n=27) patients. We found that NK cells from TBM patients showed lower absolute frequencies, higher CD69 expression, and poor expansion of the CD45RO+ memory-like subpopulation upon Mtb exposure in vitro compared to LTBI individuals. In addition, a reduction in the frequency of CD56brightCD16- NK cells characterized TBM patients but not LTBI or PTB subjects. Our study expands on earlier reports about the role of NK cells in TBM showing a reduced frequency of cytokine-producing cells compared to LTBI and PTB.
AB - The mechanisms underlying the immunopathology of tuberculous meningitis (TBM), the most severe clinical form of extrapulmonary tuberculosis (TB), are not understood. It is currently believed that the spread of Mycobacterium tuberculosis (Mtb) from the lung is an early event that occurs before the establishment of adaptive immunity. Hence, several innate immune mechanisms may participate in the containment of Mtb infection and prevent extrapulmonary disease manifestations. Natural killer (NK) cells participate in defensive processes that distinguish latent TB infection (LTBI) from active pulmonary TB (PTB). However, their role in TBM is unknown. Here, we performed a cross-sectional analysis of circulating NK cellCID="C008"value="s"phenotype in a prospective cohort of TBM patients (n=10) using flow cytometry. Also, we addressed the responses of memory-like NK cell subpopulations to the contact with Mtb antigens in vitro. Finally, we determined plasma levels of soluble NKG2D receptor ligands in our cohort of TBM patients by enzyme-linked immunosorbent assay (ELISA). Our comparative groups consisted of individuals with LTBI (n=11) and PTB (n=27) patients. We found that NK cells from TBM patients showed lower absolute frequencies, higher CD69 expression, and poor expansion of the CD45RO+ memory-like subpopulation upon Mtb exposure in vitro compared to LTBI individuals. In addition, a reduction in the frequency of CD56brightCD16- NK cells characterized TBM patients but not LTBI or PTB subjects. Our study expands on earlier reports about the role of NK cells in TBM showing a reduced frequency of cytokine-producing cells compared to LTBI and PTB.
UR - http://www.scopus.com/inward/record.url?scp=85105711189&partnerID=8YFLogxK
U2 - 10.1155/2021/5517856
DO - 10.1155/2021/5517856
M3 - Article
C2 - 34007850
AN - SCOPUS:85105711189
SN - 2314-8861
VL - 2021
JO - Journal of Immunology Research
JF - Journal of Immunology Research
M1 - 5517856
ER -